RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancer

Cancer Biology and Therapy

Volumn 8, Issue 2, 2009, Pages 174-179

  Meng, Fanping ^a   Dong, Baoxia ^b   Li, Hanwei ^a   Fan, Daiming ^b   Ding, Jie ^b  

^a BEIJING 302 HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Gastric cancer; Raf 1; siRNAi; Tumorigenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; DOUBLE STRANDED RNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RAF PROTEIN; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; RNA INTERFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

EID: 58749106068     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.2.7208     Document Type: Article

References (34)

1. Fan D, Zhang X, Chen X, Mou Z, Hu J, Zhou S, Ding J, Wu K. Bird's-eye view on gastric cancer research of the past 25 years. J Gastroenterol Hepatol 2005; 20:360-5.
2. Garcea G, Neal CP, Pattenden CJ, Steward WP, Berry DP. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005; 41: 2213-36.
3. Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 2003; 301:94-6.
4. Ehrenreiter K, Piazzolla D, Velamoor V, Sobczak I, Small JV, Takeda J, Leung T, Baccarini M. Raf-1 regulates Rho signaling and cell migration. J Cell Biol 2005; 168:955-64.
5. Wellbrock C, Karasarides M, Marais R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol 2004; 5:875-85.
6. Kerbel RS. Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed. Cancer Cell 2005; 8:269-71.
7. Li P, Wood K, Mamon H, Haser W, Roberts T. Raf-1: a kinase currently without a cause but not lacking in effects. Cell 1991; 64:479-82.
8. McManus MT and Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3:737-47.
9. Elbashir SM, Harborth J, Weber K and Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002; 26:199-213.
10. Hannon GJ. RNA interference. Nature 2002; 418:244-51.
11. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003; 19:9-12.
12. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P and Sharp PA. SiRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8:681-6.
13. Brummelkamp TR, Bernards R and Agami R. Stable suppression of tumorigenesis by virus-mediated RNA interference. Cancer Cell 2002; 2:243-7.
14. Yu JY, DeRuiter SL and Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99:6047-52.
15. Sui G, Soohoo C, Affarel B, Gay F, Shi Y and Forrester WC. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99:5515-20.
16. Brummelkamp TR, Bernards R and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-3.
17. Meng F, Ding J, Liu N, Zhang J, Shao X, Shen H, Xue Y, Xie H, Fan D. Inhibition of gastric cancer angiogenesis by vector-based RNA interference for Raf-1. Cancer Biol Ther 2005; 4:113-7.
18. Jaffe EA, Nachman RL, Becker CG and Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745-56.
19. Liang S, Lin T, Ding J, Pan Y, Dang D, Guo C, et al. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. J Mol Med 2006; 84:764-73.
20. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99:6047-52.
21. Fu YG, Sung JJ, Wu KC, Wu HP, Yu J, Chan M, et al. Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants. Cancer Lett 2005; 224:243-52.
22. Fu YG, Sung JJ, Wu KC, Bai AH, Chan MC, Yu J, Fan DM and Leung WK. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J (2) through the downregulation of angiopoietin-1. Cancer Lett 2006; 243:246-54.
23. Wang J, Wu K, Zhang D, Fan D. Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer. World J Gastroenterol 2006; 12:2450-4.
24. Vermeulen PB, Gasparini G, Fox SB. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32:2474-84.
25. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2:533-43.
26. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998; 140:1255.
27. Heidecker G, Huleihel M, Cleveland JL, et al. Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 1990; 10:2503.
28. Ferrara N and Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161:851-8.
29. Ferrara N, Houck KA, Jakeman LB, Winer J and Leung WJD. The vascular endothelial growth factor family of polypeptides. Cell Biochem 1991; 47:211-8.
30. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991; 47:219-23.
31. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature 1998; 392:405-8.
32. 2 tension. Proc Natl Acad Sci USA 1995; 92:5510-4.
33. Leng Q, Mixson AJ. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo. Cancer Gene Ther 2005; 12:682-90.
34. Liu DH, Zhang XY, Huang YX, Fan DM. VEGF165 antisense gene and biological characteristics of human gastric cancer cells. Disi Junyi Daxue Xuebao 2001; 22:821-4.